ONEM

1Life Healthcare, Inc. (ONEM) | Rumor.io

1Life Healthcare

ONEM

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about ONEM?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% new	0% 0	0% 0

Nov 2

1Life Healthcare, Inc. (ONEM) may be subject to market manipulation through deep in-the-money options buy-writes.
The SEC has documented buy-write abuse in other companies, including optionsXpress, Inc. and Sears Holdings Corp. (SHLD).
1Life Healthcare, Inc. (ONEM) may be vulnerable to fails-to-deliver in short-selling activities.

Generated by AI

Sentiment

Of the messages about ONEM that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	100% +0.47
Bearish	—	—	—	0% -0.47

Bullish· Jul 22

1Life Healthcare, Inc. has seen strong revenue growth, with a 80.66% increase in the past year, making it a very strong growth stock.
The acquisition deal with Amazon has helped the growth story and could pay off in the long run, as Amazon will need to scale the business quickly to reach positive free cash flow.
The stock has seen a significant price increase, up 70% on the news of the Amazon buyout, with a top analyst price target for next week indicating further potential for growth.

Bearish· Jul 21

The acquisition of 1Life Healthcare (ONEM) by Amazon (AMZN) for $18 a share may result in a significant loss for investors who bought the stock near its peak valuation.
The acquisition price of $18 per share is a significant discount from ONEM's peak valuation of $58, suggesting that the company's management may have made a mistake by selling low.
Investors who bought ONEM at prices above $18 may still be losing money even after the acquisition, and the stock may continue to fall by 10% or more until more certainty is established.

Generated by AI

Topics

Of the messages about ONEM that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	0%
Announcements	—	—	—	60.9%
Controversies	—	—	—	6.41%
Earnings	—	—	—	0.64%
Macro	—	—	—	32.05%
Technical Analysis	—	—	—	0%

Analysts· Jul 22

1Life Healthcare's price target was raised to $18 by Deutsche Bank Aktiengesellschaft, SVB Leerink, and Piper Sandler.
BTIG Research and Citigroup Inc. downgraded 1Life Healthcare to neutral, while Barclays downgraded it to equal-weight and raised the price target to $18.
Analysts at BTIG Research, Citigroup Inc., Barclays, and Deutsche Bank Aktiengesellschaft made changes to their ratings and price targets for 1Life Healthcare.

Announcements· Nov 15

Amazon's acquisition of One Medical in February 2023 for $3.9 billion may impact 1Life Healthcare's (ONEM) competition in the healthcare space.
One Medical's loss of a contract with Google accounted for 10% of its income, which could be a concern for the company's financials.
Amazon's discounted memberships for Prime customers may affect One Medical's membership sales and revenue.

Controversies· Mar 21

1Life Healthcare's (ONEM) acquisition by Amazon is being investigated by the FTC, with sources suggesting the agency is looking into antitrust, mergers, and privacy concerns.
The FTC is reportedly not taking action on Amazon's One Medical acquisition, despite ongoing investigations into the company's business practices.
The investigations into Amazon's business practices are expected to escalate in the coming months, with Washington preparing for a potential "war" with the tech giant.

Generated by AI

Community

Of the messages about ONEM, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	0%
Newcomers	100%	100%	100%	100%

Regulars· Feb 22

The FTC has indicated it will not block Amazon's $3.9 billion acquisition of 1Life Healthcare's One Medical, despite an initial investigation.
Amazon has completed its acquisition of One Medical, with the deal closing after the FTC's decision; the acquisition is expected to make it easier for people to get and stay healthier.
1Life Healthcare's quarterly earnings results beat estimates by $0.03 EPS, with the company's stock price experiencing a 1.40% increase on the news.

Newcomers· Nov 15

Newcomers to the market are focused on the competition between 1Life Healthcare, Inc. ($HIMS) and Amazon, with some seeing the recent price dip as a buying opportunity.
The HIMS model's resilience in the face of increased competition from Amazon is a point of interest, with some discussing the potential for Amazon to disrupt the market with its One Medical acquisition.
One Medical's focus on primary care and its potential as a loss leader for other services, such as pharmacy and medical equipment, is a concern for some, who see Amazon's ability to absorb losses as a threat to the HIMS business model.

Generated by AI

Also Discussed

Investors talking about ONEM also mention

#	Name	Attention
1	OSH - Oak Street Health, Inc.	——
2	Teladoc Health Inc.TDOC	0%+0
3	ACCD - Accolade, Inc.	——
4	BHG - Bright Health Group, Inc.	——
5	American Well Corporation Class A Common StockAMWL	0%+0
6	Alignment Healthcare, Inc.ALHC	0%0
7	ZoomInfo Technologies Inc.GTM	0%0
8	OTRK - Ontrak, Inc.	——
9	GoodRx Holdings, Inc. Class A Common StockGDRX	0%new
10	Dynatrace Inc.DT	0%0